View : 630 Download: 0

Full metadata record

DC Field Value Language
dc.contributor.author김대기*
dc.date.accessioned2017-02-15T08:02:47Z-
dc.date.available2017-02-15T08:02:47Z-
dc.date.issued2006*
dc.identifier.issn0362-4803*
dc.identifier.otherOAK-3711*
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/234188-
dc.description.abstractA new 14C-labelled PDE5 inhibitor, 5-ethyl-2-{5-[4-(2- hydroxyethyl)piperazin-1-ylsulfonyl]-2-n-propoxyphenyl}-7-n-propyl-3, 5-dihydro-4H-pyrrolo[3,2-d]-[2-14C]pyrimidin-4-one · 2 HCl (14C-SK3530 · 2 HCl) (1-2 HCl) was synthesized through a straightforward six-step sequence from the readily available [ 14C-carbonyl]methyl salicylate (2). The overall radiochemical yield of the 1 · 2 HCl from 2 was 10.5%, and its radiochemical purity was 98.8%. Copyright © 2006 John Wiley & Sons, Ltd.*
dc.languageEnglish*
dc.titleSynthesis of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazin-1-ylsulfonyl]-2-n- propoxyphenyl}-7-n-propyl-3,5-dihydro-4H-pyrrolo[3,2-d]-[2-14C] pyrimidin-4-one · 2 HCl (14C-SK3530 · 2 HCl)*
dc.typeArticle*
dc.relation.issue13*
dc.relation.volume49*
dc.relation.indexSCI*
dc.relation.indexSCIE*
dc.relation.indexSCOPUS*
dc.relation.startpage1141*
dc.relation.lastpage1149*
dc.relation.journaltitleJournal of Labelled Compounds and Radiopharmaceuticals*
dc.identifier.doi10.1002/jlcr.1116*
dc.identifier.wosidWOS:000242796700002*
dc.identifier.scopusid2-s2.0-33845479238*
dc.author.googleShin H.-I.*
dc.author.googleLee J.*
dc.author.googleKim D.-K.*
dc.contributor.scopusid김대기(35083694200)*
dc.date.modifydate20240118164500*
Appears in Collections:
약학대학 > 약학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE